SG Americas Securities
ADVM

SG Americas Securities’s Adverum Biotechnologies ADVM Stock Holding History

SG Americas Securities’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,597
Closed -$74K – 3102
2024
Q3 		$74K Buy
+10,597
New +$76.9K ﹤0.01% 3151
2022
Q2 		– Sell
-1,257
Closed -$16K – 3395
2022
Q1 		$16K Sell
1,257
-1,192
-49% -$17.4K ﹤0.01% 2893
2021
Q4 		$43K Sell
2,449
-4,444
-64% -$89K ﹤0.01% 3208
2021
Q3 		$150K Buy
+6,893
New +$176K ﹤0.01% 3435
2021
Q2 		– Sell
-2,059
Closed -$203K – 2820
2021
Q1 		$203K Buy
2,059
+549
+36% +$65.9K ﹤0.01% 2671
2020
Q4 		$164K Sell
1,510
-8,315
-85% -$1.03M ﹤0.01% 2740
2020
Q3 		$1.01M Buy
9,825
+8,660
+743% +$1.3M 0.01% 1161
2020
Q2 		$243K Sell
1,165
-3,774
-76% -$668K ﹤0.01% 2695
2020
Q1 		$483K Buy
+4,939
New +$576K ﹤0.01% 1872
2019
Q4 		– Sell
-3,754
Closed -$205K – 3258
2019
Q3 		$205K Buy
+3,754
New +$423K ﹤0.01% 2339
2019
Q2 		– Sell
-1,136
Closed -$60K – 3042
2019
Q1 		$60K Buy
+1,136
New +$45.9K ﹤0.01% 3159
2018
Q3 		– Sell
-1,078
Closed -$57K – 3104
2018
Q2 		$57K Buy
+1,078
New +$64.8K ﹤0.01% 3152
2015
Q1 		– Sell
-426
Closed -$230K – 2484
2014
Q4 		$230K Buy
+426
New +$164K ﹤0.01% 2304

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SG Americas Securities's ADVM Position: Q4 2024 in Review

SG Americas Securities sold out of Adverum Biotechnologies (ADVM) in Q4 2024, closing a stake of 10,597 shares — an estimated $74K sold.

SG Americas Securities first reported a position in ADVM in Q4 2014 and held it in 13 quarters. The position peaked at $1.01M in Q3 2020. 69 funds tracked by Wall St. Rank hold ADVM as of Q4 2024.

  • SG Americas Securities reported no remaining Adverum Biotechnologies position as of Q4 2024 after selling out during the quarter.
  • SG Americas Securities sold 10,597 Adverum Biotechnologies shares in Q4 2024, an estimated $74K.
  • SG Americas Securities first reported a position in Adverum Biotechnologies in Q4 2014 and held it in 13 quarters.
  • SG Americas Securities's Adverum Biotechnologies position peaked at $1.01M in Q3 2020.
  • 69 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2024.

Based on SG Americas Securities's 13F filing for Q4 2024, filed 17 Jan 2025.